Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald S Baim

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Journal of the American College of Cardiology|September 15, 2004
Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent proceduresAllen Jeremias, Donald S Baim, Kalon K L Ho, et al.
Circulation|July 1, 2004
Post-market approval surveillance: a call for a more integrated and comprehensive approachRoxana Mehran, Martin B Leon, David A Feigal, et al.
Circulation|March 20, 2002
Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass graftsDonald S Baim, Dennis Wahr, Barry George, et al.
JACC. Cardiovascular Interventions|April 20, 2010
The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesionsTakahiro Uchida, Jeffrey Popma, Gregg W Stone, et al.
The American Journal of Cardiology|May 29, 2004
Effects of stent length and lesion length on coronary restenosisLaura Mauri, A James O'Malley, Donald E Cutlip, et al.
The American Journal of Cardiology|September 5, 2006
Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials)Tobias T Lee, Loryn Feinberg, Donald S Baim, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 17, 2008
Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ: 1-year results in the CABERNET trialL Nelson Hopkins, Subbarao Myla, Eberhard Grube, et al.
JACC. Cardiovascular Interventions|February 5, 2010
Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent)Stephen G Ellis, Gregg W Stone, David A Cox, et al.
Circulation|September 1, 2004
Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trialsDonald E Cutlip, Amit G Chhabra, Donald S Baim, et al.
Circulation|May 5, 2004
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudyIssam Moussa, Martin B Leon, Donald S Baim, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Journal of the American College of Cardiology|September 15, 2004
Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent proceduresAllen Jeremias, Donald S Baim, Kalon K L Ho, et al.
Circulation|July 1, 2004
Post-market approval surveillance: a call for a more integrated and comprehensive approachRoxana Mehran, Martin B Leon, David A Feigal, et al.
Circulation|March 20, 2002
Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass graftsDonald S Baim, Dennis Wahr, Barry George, et al.
JACC. Cardiovascular Interventions|April 20, 2010
The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesionsTakahiro Uchida, Jeffrey Popma, Gregg W Stone, et al.
The American Journal of Cardiology|May 29, 2004
Effects of stent length and lesion length on coronary restenosisLaura Mauri, A James O'Malley, Donald E Cutlip, et al.
The American Journal of Cardiology|September 5, 2006
Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials)Tobias T Lee, Loryn Feinberg, Donald S Baim, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 17, 2008
Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ: 1-year results in the CABERNET trialL Nelson Hopkins, Subbarao Myla, Eberhard Grube, et al.
JACC. Cardiovascular Interventions|February 5, 2010
Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent)Stephen G Ellis, Gregg W Stone, David A Cox, et al.
Circulation|September 1, 2004
Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trialsDonald E Cutlip, Amit G Chhabra, Donald S Baim, et al.
Circulation|May 5, 2004
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudyIssam Moussa, Martin B Leon, Donald S Baim, et al.
Pageof 7